R&D Solutions segment profit margin is a derived ratio: R&D Solutions segment profit divided by R&D Solutions revenue.
Using IQVIA's Q2 2026 figures, $526M / $2.575B = about 20.4%, versus about 20.0% a year earlier from $473M / $2.366B.
Reimbursed expenses can affect the denominator
IQVIA includes reimbursed expenses such as investigator payments and certain travel in cost of revenue, and related pass-through activity can affect reported revenue growth. That is one reason to read the margin with R&D Solutions revenue rather than treating it as a pure labor-productivity measure.
The ratio is also based on IQVIA's segment profit, not consolidated GAAP operating income.
Primary sources: IQVIA Q2 2026 Form 10-Q and Q2 2026 earnings release filed with the SEC.
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare stocks
Compare outsourced R&D profit conversion while preserving issuer-specific segment accounting and pass-through expense mix.
Explore more topics in the Financial Research Encyclopedia.